|
|
Volumn 4, Issue 12, 2005, Pages 947-
|
|
First phase of HapMap project already helping drug discovery
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DNA;
LEUKOTRIENE A4 HYDROLASE;
REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);
WARFARIN;
DIAGNOSTIC AGENT;
EPOXIDE HYDROLASE;
AFRICAN AMERICAN;
BLOOD CLOTTING DISORDER;
CLINICAL TRIAL;
COMPUTER PROGRAM;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG INFORMATION;
DRUG MEGADOSE;
DRUG RESEARCH;
DRUG RESPONSE;
ETHNOLOGY;
GENE IDENTIFICATION;
GENE MUTATION;
GENETIC VARIABILITY;
GENOME ANALYSIS;
GENOTYPE;
HAPLOTYPE;
HEART INFARCTION;
HUMAN;
HUMAN GENOME;
LOW DRUG DOSE;
NOTE;
PHARMACOGENOMICS;
PREDICTION;
PRIORITY JOURNAL;
RISK ASSESSMENT;
SINGLE NUCLEOTIDE POLYMORPHISM;
STATISTICAL ANALYSIS;
ARTICLE;
DRUG DESIGN;
GENETIC PREDISPOSITION;
GENETICS;
GENOME;
INTERNATIONAL COOPERATION;
LABORATORY;
METHODOLOGY;
ORGANIZATION AND MANAGEMENT;
PHARMACOGENETICS;
STANDARD;
DRUG DESIGN;
DRUG INDUSTRY;
EPOXIDE HYDROLASES;
GENETIC PREDISPOSITION TO DISEASE;
GENOME, HUMAN;
HUMANS;
INTERNATIONAL COOPERATION;
LABORATORIES;
PHARMACOGENETICS;
POLYMORPHISM, SINGLE NUCLEOTIDE;
|
|
EID: 33644679757
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd1918 Document Type: Note |
|
Times cited : (12)
|
|
References (0)
|